Ophthalmology ManagementIntegrating Photobiomodulation Into Retina Practice

⚠️ Small Study / Early Comparative Evidence

Photobiomodulation (PBM) recently entered clinical retina practice following FDA approval for intermediate AMD based on the LIGHTSITE III program. In this implementation report, a large multisite retina practice describes its initial experience incorporating PBM into routine care. The therapy uses multiple wavelengths of light targeting mitochondrial function and oxidative stress pathways and offers a noninvasive treatment option requiring nine sessions over approximately one month. While early trial results demonstrated visual acuity improvements, the author notes that real-world effectiveness, treatment durability, and optimal treatment duration remain uncertain.

Clinical Considerations

• PBM was approved for intermediate AMD, supported by LIGHTSITE III findings demonstrating BCVA improvement versus sham treatment.
• Treatment is noninvasive, requires no dilation or anesthesia, and takes less than five minutes per eye.
• The protocol requires nine treatment sessions over roughly one month, creating substantial patient adherence and scheduling demands.
• Candidate selection mirrors the trial population, particularly patients with intermediate AMD, visual acuity between 20/32 and 20/100, and no concurrent neovascular AMD.
• Medicare coverage was available in the author’s region, while commercial and Medicare Advantage coverage remained variable and often required prior authorization.
• The author identifies uncertain long-term benefit, unclear treatment endpoints, and limited real-world evidence as the primary barriers to broader adoption.

Practice Applications

• Consider PBM as an emerging option for appropriately selected patients with intermediate AMD who resemble the studied population.
• Recognize that current implementation decisions rely on relatively limited clinical and real-world experience.
• Monitor future post-approval studies and registry data to better define durability, retreatment frequency, and patient selection.
• Review staffing, scheduling, reimbursement, and documentation requirements before integrating PBM into clinic workflows.
• Interpret reported benefits cautiously until larger real-world datasets confirm outcomes observed in registration studies.